BK
66
3
CCL
50
3
VIX
33
3
CHD
64
-3
KO
57
5
EFX
66
11
RCL
66
4
SWN
46
16
CL
77
2
FRT
45
6
MMM
33
3
RF
47
4
GRMN
61
2
PM
60
8
VZ
29
5
MHK
45
5
ACN
42
-16
FLR
38
2
AIG
53
2
WFC
61
3
BK
66
3
CCL
50
3
VIX
33
3
CHD
64
-3
KO
57
5
EFX
66
11
RCL
66
4
SWN
46
16
CL
77
2
FRT
45
6
MMM
33
3
RF
47
4
GRMN
61
2
PM
60
8
VZ
29
5
MHK
45
5
ACN
42
-16
FLR
38
2
AIG
53
2
WFC
61
3
Financhill
Back

National Australia Bank Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
59

NABZY
National Australia Bank

Last Price:
12.08
Seasonality Move:
1.51%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.82
Seasonality Move:
-0.9%
Buy
59
National Australia Bank (NABZY) is a Buy

Is National Australia Bank a Buy, Sell or Hold?

  • The current National Australia Bank [NABZY] share price is $11.95. The Score for NABZY is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • NABZY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.39. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NABZY Stock Price Chart

What is National Australia Bank's stock price today?

  • The National Australia Bank share price today is $11.95
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NABZY is experiencing slight buying pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.39
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

NABZY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.16 Buy
Relative Strength Index (14 RSI): 63.58 Buy
Chaikin Money Flow: 21313 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.28 - 11.78) Buy
Bollinger Bands (100): (10.83 - 11.55) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.74 Sell
Relative Strength Index (14 RSI): 45.16 Sell
Chaikin Money Flow: -377368 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.89 - 42.13) Sell
Bollinger Bands (100): (40.93 - 48.81) Sell

NABZY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.76 Buy
20-day SMA: 11.54 Buy
50-day SMA: 11.32 Buy
200-day SMA: 10.4 Buy
8-day EMA: 11.8 Buy
20-day EMA: 11.62 Buy
50-day EMA: 11.41 Buy
200-day EMA: 10.66 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.13 Sell
20-day SMA: 40.38 Sell
50-day SMA: 41.72 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.68 Sell
20-day EMA: 40.43 Sell
50-day EMA: 41.92 Sell
200-day EMA: 43.42 Sell

National Australia Bank Earnings Growth & NABZY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.02 per share, and an increase next year of $0.03 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

National Australia Bank Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):